Uncovering additional predictors of urothelial carcinoma from voided urothelial cell clusters through a deep learning-based image preprocessing technique.

Journal: Cancer cytopathology
PMID:

Abstract

BACKGROUND: Urine cytology is commonly used as a screening test for high-grade urothelial carcinoma for patients with risk factors or hematuria and is an essential step in longitudinal monitoring of patients with previous bladder cancer history. However, the semisubjective nature of current reporting systems for urine cytology (e.g., The Paris System) can hamper reproducibility. For instance, the incorporation of urothelial cell clusters into the classification schema is still an item of debate and perplexity among expert cytopathologists because several previous works have disputed their diagnostic relevance.

Authors

  • Joshua J Levy
    DOE Joint Genome Institute, 2800 Mitchell Dr, Walnut Creek, CA, 94598, USA.
  • Xiaoying Liu
    Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Jonathan D Marotti
    Department of Pathology and Laboratory Medicine, Lebanon, USA.
  • Darcy A Kerr
    Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Edward J Gutmann
    Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon.
  • Ryan E Glass
    University of Pennsylvania Medical Center East, Pittsburgh, Pennsylvania, USA.
  • Caroline P Dodge
    Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.
  • Arief A Suriawinata
    Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Louis J Vaickus
    Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.